Allergan (AGN) Acquires Akarna Therapeutics in $50M + Milestones Deal
Tweet Send to a Friend
Allergan (NYSE: AGN) announced that the Company has acquired Akarna Therapeutics Ltd., a privately held biopharmaceutical company focused on developing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE